You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Summary of freedom from biochemical failure (FFBF) and toxicity with various radiation modalities used to treat high risk prostate cancer

From: Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study

Author Year Modality FFBF GU toxicity (G2-3) GI toxicity (G2-3)
Zelefsky [27] 2006 IMRT (81 Gy in 45 fx) 62% 15% 3%
Kupelian [8] 2007 IMRT (70 Gy in 28 fx) 69% 5.20% 4.40%
Zelefsky [31] 2011 EBRT + LDR boost 58% 17.80% 6.20%
Potters [28] 2005 EBRT + LDR boost 63% 15.80% 6.60%
Galalae [29] 2004 EBRT + HDR boost 69% 23% 4.10%
Demanes [30] 2005 EBRT + HDR boost 69% 7.70% 2%